Markets:

Overview

News

Currencies

International

Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)

9.230 -0.130 (-1.39%)

Delayed Quote Updated: 4:00 PM EST, Nov 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push ↗

November 04, 2026

Telix Pharmaceuticals (NASDAQ:TLX) outlined its commercial growth strategy, late-stage radiopharmaceutical pipeline and planned integration of ITM at an investor event in Melbourne, with management...

Via MarketBeat

Topics Economy

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

September 15, 2026

Via Chartmill

Telix Pharmaceuticals H1 Earnings Call Highlights ↗

August 19, 2026

Telix Pharmaceuticals (NASDAQ:TLX) reported first-half 2026 revenue of $477 million, up 22% from the prior-year period, as demand for its precision medicine imaging products continued to grow. The...

Via MarketBeat

Topics Earnings

The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)

April 13, 2026

As of April 13, 2026, Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX) stands as a pivotal player in the rapidly evolving field of radiopharmaceuticals—a sector that has transformed from a niche...

Via Finterra

Topics Economy Initial Public Offering

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth ↗

February 26, 2026

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.

Via The Motley Fool

Topics Artificial Intelligence

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance ↗

October 14, 2025

Telix Pharmaceuticals posts 53% Q3 revenue growth to $206 million, lifts FY25 guidance to up to $820 million amid strong PSMA imaging and reimbursement gains.

Via Benzinga

Telix Gets Second FDA Rejection For Kidney Cancer Drug ↗

August 28, 2025

FDA sent a second CRL to Telix, delaying its kidney cancer PET drug. Analysts weigh pricing pressure, and growth opportunities.

Via Benzinga

Cooper Companies Posts Downbeat Sales, Joins NetApp, Urban Outfitters, Nvidia And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗

August 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 28, 2025

Via Benzinga

Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

August 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

Texas Instruments, SAP, Enphase Energy And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗

July 23, 2025

Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.

Via Benzinga

Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains ↗

July 03, 2025

Via Benzinga

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday ↗

July 03, 2025

Via Benzinga

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 05, 2025

Via Benzinga

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients ↗

April 16, 2025

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Via Benzinga

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? ↗

April 13, 2025

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

Via Benzinga

Five Below, Telix Pharmaceuticals, Dollar Tree And Other Big Stocks Moving Higher On Monday ↗

April 07, 2025

Via Benzinga

Bridge Investment Group, Telix Pharmaceuticals, Sun Communities, And Other Big Stocks Moving Higher On Monday ↗

February 24, 2025

Via Benzinga

Stock Rebound Stalls; Nasdaq Down Triple Digits ↗

February 24, 2025

Stocks have pulled back from their premarket gains, with the Nasdaq Composite down 163 points and oscillating in and out of negative territory for 2025.

Via Talk Markets

Topics Stocks Stocks / Equities

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 10, 2025

Via Benzinga

SLB Posts Upbeat Results, Joins Bank OZK, Qorvo And Other Big Stocks Moving Higher On Friday ↗

January 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 12, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.